HCA Healthcare, Inc. (HCA) is next scheduled to report earnings on Jul 24, 2026. The consensus analyst EPS estimate for the upcoming quarter is $7.37.
Heading into this report, the model's fair value estimate sits 8.9% below the current price (model fair value differential below current price). Descriptive context only — not a forecast of the earnings result.
Equity Rank computed model fair value for HCA from 10 independent valuation methods with sufficient data. 2 place fair value above the current price of $406.60, and 8 place it below. The model-blended estimate lands at $370.52 — a model fair value differential of 8.9% below the current price under these model assumptions. The larger group places fair value below the current price.
Equity Rank's fundamental strength composite scores HCA at 78.0/100 (A-, Strong), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, free cash flow has compounded at +23.1% per year and gross margin has moved +3.0 pp. Its SAVE composite score has moved +0.2 over the past 30 days.
HCA Healthcare, Inc. (HCA) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.
Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.
Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator